BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib

Por Dufour, Robin, Daumar, Pierre, Mounetou, Emmanuelle, Aubel, Corinne, Kwiatkowski, Fabrice, Abrial, Catherine, Vatoux, Catherine, Penault-Llorca, Frédérique, Bamdad, Mahchid
Publicado no Sci Rep (2015)

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials

Por Abrial, Catherine, Durando, Xavier, Mouret-Reynier, Marie-Ange, Thivat, Emilie, Bayet-Robert, Mathilde, Nayl, Béatrice, Dubray, Pascale, Pomel, Christophe, Chollet, Philippe, Penault-Llorca, F
Publicado em 2009

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse

Por Thivat, Emilie, Thérondel, Sophie, Lapirot, Olivier, Abrial, Catherine, Gimbergues, Pierre, Gadéa, Emilie, Planchat, Eloïse, Kwiatkowski, Fabrice, Mouret-Reynier, Marie A, Chollet, Philippe, Durando, Xavier
Publicado em 2010

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

Por Gay‐Bellile, Mathilde, Romero, Pierre, Cayre, Anne, Véronèse, Lauren, Privat, Maud, Singh, Shalini, Combes, Patricia, Kwiatkowski, Fabrice, Abrial, Catherine, Bignon, Yves‐Jean, Vago, Philippe, Penault‐Llorca, Frédérique, Tchirkov, Andreï
Publicado no J Pathol Clin Res (2016)

Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Nega...

Por Wang-Lopez, Qian, Mouret-Reynier, Marie-Ange, Savoye, Aude-Marie, Abrial, Catherine, Kwiatkowski, Fabrice, Garbar, Christian, DuBray-Longeras, Pascale, Eymard, Jean-Christophe, Lebouedec, Guillaume, Vanpraagh, Isabelle, Penault-Llorca, Frederique, Chollet, Philippe, Cure, Hervé
Publicado no Oncologist (2015)